AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27244221 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human Bile Salt-Stimulated Lipase (rhBSSL) in small for gestational age infants
Number of subjects: 415
Study 27244221 — intervention group
Group type: COMPARATOR
Intervention: Placebo in small for gestational age infants
Number of subjects: 415
Study 25514519 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time neurofeedback training of alpha lateralization
Number of subjects: 0
Study 25514519 — intervention group
Group type: COMPARATOR
Intervention: Sham feedback (Control)
Number of subjects: 0
Study 23866835 — intervention group
Group type: EXPERIMENTAL
Intervention: Granule group at 10 grams, three times daily (G10 group)
Number of subjects: 48
Study 23866835 — intervention group
Group type: EXPERIMENTAL
Intervention: Granule group at 20 grams, three times daily (G20 group)
Number of subjects: 48
Study 23866835 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoction group (D group)
Number of subjects: 48
Study 23866835 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan group (Aprovel group)
Number of subjects: 48
Study 21096598 — intervention group
Group type: EXPERIMENTAL
Intervention: Anisotropic diffusion tensor measurements
Number of subjects: 0
Study 21096598 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical learning scheme
Number of subjects: 0
Study 21096598 — intervention group
Group type: EXPERIMENTAL
Intervention: Orientation of breast tissue changes
Number of subjects: 0
Study 18796444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 26
Study 18796444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 17165497 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion and acupuncture at Zusanli (ST 36) plus acupuncture at Hegu (LI 4), Taichong (LR 3), Touwei (ST 8)
Number of subjects: 60
Study 17165497 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at Hegu (LI 4), Taichong (LR 3), Touwei (ST 8)
Number of subjects: 60
Study 17165497 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion and acupuncture at Zusanli (ST 36) with needling sensation propagating along the channel
Number of subjects: 60
Study 17165497 — intervention group
Group type: EXPERIMENTAL
Intervention: No needling sensation propagating along the channel
Number of subjects: 60
Study 14586349 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (100 microg every 6 hours to a maximum of two doses)
Number of subjects: 305
Study 14586349 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 305
Study 14586349 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 305
Study 11220772 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemotil (ARTECEF)
Number of subjects: 92
Study 11220772 — intervention group
Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 92
Study 8814200 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% amylopectin cornstarch
Number of subjects: 22
Study 8814200 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% amylose cornstarch
Number of subjects: 22
Study 8814200 — intervention group
Group type: EXPERIMENTAL
Intervention: Excess energy intake (125% of maintenance energy)
Number of subjects: 22
Study 8814200 — intervention group
Group type: EXPERIMENTAL
Intervention: High amylose consumption
Number of subjects: 22
Study 8814200 — intervention group
Group type: EXPERIMENTAL
Intervention: High amylopectin starch with excess energy intake
Number of subjects: 22
Study 8814200 — intervention group
Group type: EXPERIMENTAL
Intervention: High amylose diet with excess energy intake
Number of subjects: 22
Study 29455696 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulating Emotions and Changing Habits (REaCH)
Number of subjects: 22
Study 29455696 — intervention group
Group type: COMPARATOR
Intervention: Supportive Psychotherapy
Number of subjects: 22
Study 27595716 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Tandem Appliance (MTA)
Number of subjects: 32
Study 27595716 — intervention group
Group type: COMPARATOR
Intervention: Facemask (FM)
Number of subjects: 32
Study 25611935 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional school schedule
Number of subjects: 168
Study 25611935 — intervention group
Group type: COMPARATOR
Intervention: Modified block school schedule
Number of subjects: 168
Study 23117076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention effects assessed at 3.5 years post intervention
Number of subjects: 492
Study 23117076 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further intervention)
Number of subjects: 492
Study 21359104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis use (A)
Number of subjects: 13
Study 21359104 — intervention group
Group type: COMPARATOR
Intervention: Cannabis abstinence (B/C)
Number of subjects: 13
Study 21359104 — intervention group
Group type: COMPARATOR
Intervention: Morning assessments during abstinence
Number of subjects: 13
Study 18540736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral relaxation training (RLXN)
Number of subjects: 252
Study 18540736 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused tai chi training (TCHI)
Number of subjects: 252
Study 18540736 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual growth groups (SPRT)
Number of subjects: 252
Study 18540736 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control group (CTRL)
Number of subjects: 252
Study 16019795 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose group (1.5 g/day)
Number of subjects: 50
Study 16019795 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose group (3.0 g/day)
Number of subjects: 50
Study 16019795 — intervention group
Group type: COMPARATOR
Intervention: Both groups (1.5 g/day and 3.0 g/day)
Number of subjects: 50
Study 12383077 — intervention group
Group type: EXPERIMENTAL
Intervention: ERHOX (hyperoxic air during entire exercise and recovery)
Number of subjects: 9
Study 12383077 — intervention group
Group type: EXPERIMENTAL
Intervention: RHOX (hyperoxic air only during recovery)
Number of subjects: 9
Study 12383077 — intervention group
Group type: COMPARATOR
Intervention: NOX (normoxia)
Number of subjects: 9
Study 10515023 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold intraoperative wound irrigation with a cold (18 C) 5% bacitracin solution for 5 minutes and postoperative wound cooling with a microtemperature pump for 24 hours.
Number of subjects: 70
Study 10515023 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care without additional hypothermic therapy (control group).
Number of subjects: 70
Study 7492035 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated 2% lidocaine (42 degrees C)
Number of subjects: 20
Study 7492035 — intervention group
Group type: COMPARATOR
Intervention: Room-temperature 2% lidocaine (21 degrees C)
Number of subjects: 20
Study 1837763 — intervention group
Group type: EXPERIMENTAL
Intervention: Short wave therapy (460 MHz, 50‐60 W, for 8‐20 minutes)
Number of subjects: 120
Study 6782146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (CS) inhalant
Number of subjects: 30
Study 6782146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30107984 — intervention group
Group type: EXPERIMENTAL
Intervention: Depth jumps (DJ)
Number of subjects: 17
Study 30107984 — intervention group
Group type: COMPARATOR
Intervention: Control condition (body weight quarter squats)
Number of subjects: 17
Study 28067612 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming group (negative aging stereotype activated)
Number of subjects: 120
Study 28067612 — intervention group
Group type: COMPARATOR
Intervention: Control group (no priming)
Number of subjects: 120
Study 27136908 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg/day under fasted conditions (Period-1)
Number of subjects: 0
Study 27136908 — intervention group
Group type: COMPARATOR
Intervention: Canagliflozin 300 mg/day under fed conditions (Period-2)
Number of subjects: 0
Study 27136908 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 50 mg, 100 mg, and 300 mg (in a 3-way crossover study)
Number of subjects: 0
Study 24150778 — intervention group
Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate)
Number of subjects: 0
Study 24150778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21191850 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0
Study 21191850 — intervention group
Group type: COMPARATOR
Intervention: Sample size calculation procedure
Number of subjects: 0
Study 19318534 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based smoking cessation support intervention
Number of subjects: 200
Study 19318534 — intervention group
Group type: COMPARATOR
Intervention: Pooled effect estimate from txt2stop and STOMP trials
Number of subjects: 200
Study 17673580 — intervention group
Group type: COMPARATOR
Intervention: Fondaparinux
Number of subjects: 795
Study 17673580 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux plus compression stockings
Number of subjects: 795
Study 14748864 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (screening and treatment for depression by resident physicians)
Number of subjects: 61
Study 14748864 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (provided results of the screen and advised to seek care)
Number of subjects: 61
Study 11330928 — intervention group
Group type: EXPERIMENTAL
Intervention: DIAGNOdent device
Number of subjects: 240
Study 11330928 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinical methods
Number of subjects: 240
Study 9213940 — intervention group
Group type: EXPERIMENTAL
Intervention: Taping and oral NSAID proglumetacine b.i.d. (26 patients)
Number of subjects: 48
Study 9213940 — intervention group
Group type: COMPARATOR
Intervention: Taping and oral placebo b.i.d. (22 patients)
Number of subjects: 48
Study 8424422 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg intravenously every 8 hours for nine doses
Number of subjects: 77
Study 8424422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 3300532 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 84
Study 3300532 — intervention group
Group type: COMPARATOR
Intervention: Nalidixic acid
Number of subjects: 84
Study 30937304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive nutritional counseling (INC)
Number of subjects: 58
Study 30937304 — intervention group
Group type: COMPARATOR
Intervention: On-demand nutritional counseling (ODC)
Number of subjects: 58
Study 30937304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both INC and ODC
Number of subjects: 58
Study 28253900 — intervention group
Group type: EXPERIMENTAL
Intervention: LOCI intervention (leadership training for workgroup leaders, ongoing implementation leadership coaching, 360° assessment, and strategic planning)
Number of subjects: 420
Study 28253900 — intervention group
Group type: COMPARATOR
Intervention: Webinar leadership training control condition
Number of subjects: 420
Study 25597529 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigeminal nerve stimulation (TNS)
Number of subjects: 40
Study 25597529 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 40
Study 23438483 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab weekly dosing
Number of subjects: 498
Study 23438483 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab every other week (eow) dosing
Number of subjects: 498
Study 23438483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study 21617556 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve block anesthesia at the wrist with 1% lidocaine followed by standard injection
Number of subjects: 19
Study 21617556 — intervention group
Group type: COMPARATOR
Intervention: Standard injection alone using 1-needle 2-syringe technique with 0.5 mL 1% lidocaine and 20 mg triamcinolone acetonide
Number of subjects: 19
Study 18433305 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (2000 mg calcium and 800 IU vitamin D/d)
Number of subjects: 5201
Study 18433305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5201
Study 17202633 — intervention group
Group type: EXPERIMENTAL
Intervention: Miltefosine (2.5 mg/Kg/day, orally, o.d. or b.i.d., max 100 mg)
Number of subjects: 125
Study 17202633 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (1 mg/Kg/day, total 15 mg/Kg)
Number of subjects: 125
Study 12783417 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta1a 22 microg subcutaneously once weekly
Number of subjects: 309
Study 10189772 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental form of therapy of indeterminate benefit
Number of subjects: 654
Study 10189772 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trial of two therapies
Number of subjects: 654
Study 8610312 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased common carotid intima-media thickness (CC-IMT)
Number of subjects: 64
Study 8610312 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor VII (FVII) levels
Number of subjects: 64
Study 8610312 — intervention group
Group type: EXPERIMENTAL
Intervention: von Willebrand factor (vWF) levels
Number of subjects: 64
Study 8610312 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor VII (FVII) as an independent variable
Number of subjects: 64
Study 1928569 — intervention group
Group type: EXPERIMENTAL
Intervention: Levo-praziquantel (20 mg/kg)
Number of subjects: 278
Study 1928569 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel (40 mg/kg)
Number of subjects: 278
Study 6651596 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% viscous solution of phenylephrine hydrochloride
Number of subjects: 3
Study 6651596 — intervention group
Group type: COMPARATOR
Intervention: 2.5% aqueous solution of phenylephrine hydrochloride
Number of subjects: 3
Study 30678193 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart cherry juice (480 mL daily for 12 weeks)
Number of subjects: 37
Study 29745970 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 110
Study 29745970 — intervention group
Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT)
Number of subjects: 110
Study 28361746 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet for two months
Number of subjects: 90
Study 28361746 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 26583678 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Distal Pancreatectomy (LapDP)
Number of subjects: 2753
Study 26583678 — intervention group
Group type: COMPARATOR
Intervention: Open Distal Pancreatectomy (OpenDP)
Number of subjects: 2753
Study 23839181 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical brimonidine tartrate gel 0.5%
Number of subjects: 2
Study 23839181 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 2
Study 22379915 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA with trimeperidine and ketoprofen
Number of subjects: 75
Study 22379915 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA with only trimeperidine
Number of subjects: 75
Study 22379915 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen combined with intramuscular injection of trimeperidine
Number of subjects: 75
Study 18571251 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 96
Study 18571251 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 96
Study 16461817 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 458
Study 16461817 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (STD)
Number of subjects: 458
Study 15265537 — intervention group
Group type: COMPARATOR
Intervention: Neutrophils from astronauts after 5-day mission
Number of subjects: 34
Study 15265537 — intervention group
Group type: COMPARATOR
Intervention: Neutrophils from astronauts after 9- to 11-day missions
Number of subjects: 34
Study 15265537 — intervention group
Group type: COMPARATOR
Intervention: Neutrophils from astronauts before and after space missions
Number of subjects: 34
Study 15265537 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophils from astronauts at landing
Number of subjects: 34
Study 11679455 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard group received insulin treatment
Number of subjects: 98
Study 11679455 — intervention group
Group type: COMPARATOR
Intervention: Experimental group received insulin if AC >70th percentile and/or FPG >120 mg/dl
Number of subjects: 98
Study 11679455 — intervention group
Group type: COMPARATOR
Intervention: Standard group
Number of subjects: 98
Study 11679455 — intervention group
Group type: COMPARATOR
Intervention: Experimental group (infants of women who did not receive insulin)
Number of subjects: 98
Study 9447368 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydralazine (5 mg, repeated every 20 min up to 4 doses)
Number of subjects: 80
Study 9447368 — intervention group
Group type: COMPARATOR
Intervention: Ketanserin (10 mg, repeated every 20 min up to 4 doses)
Number of subjects: 80
Study 9447368 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydralazine
Number of subjects: 80
Study 9447368 — intervention group
Group type: COMPARATOR
Intervention: Ketanserin
Number of subjects: 80
Study 8199822 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkali citrate therapy (group II, n = 25)
Number of subjects: 50
Study 8199822 — intervention group
Group type: COMPARATOR
Intervention: General prophylactic instructions (group I, n = 25)
Number of subjects: 50
Study 3266072 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 280
Study 3266072 — intervention group
Group type: COMPARATOR
Intervention: Sham machines (Control)
Number of subjects: 280
Study 29630549 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis (0.83 g, n=30)
Number of subjects: 60
Study 29630549 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=30)
Number of subjects: 60
Study 26562046 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP goal of <120 mm Hg
Number of subjects: 16800000
Study 26562046 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated hypertension
Number of subjects: 16800000
Study 26562046 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall U.S. population
Number of subjects: 16800000
Study 26562046 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and gender
Number of subjects: 16800000
Study 26562046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethnicity
Number of subjects: 16800000
Study 26562046 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated hypertension
Number of subjects: 16800000
Study 25203483 — intervention group
Group type: EXPERIMENTAL
Intervention: One-sample FIT kit (1-FIT)
Number of subjects: 3081
Study 25203483 — intervention group
Group type: COMPARATOR
Intervention: Two-sample FIT kit (2-FIT)
Number of subjects: 3081
Study 24068048 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity constant-power exercise with 18 s recovery
Number of subjects: 9
Study 24068048 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity constant-power exercise with 30 s recovery
Number of subjects: 9
Study 24068048 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity constant-power exercise with 48 s recovery
Number of subjects: 9
Study 24068048 — intervention group
Group type: EXPERIMENTAL
Intervention: All intermittent protocols
Number of subjects: 9
Study 24068048 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery of intramuscular phosphocreatine concentration
Number of subjects: 9
Study 24068048 — intervention group
Group type: EXPERIMENTAL
Intervention: W>CP in excess of W'
Number of subjects: 9
Study 21417560 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous COC (levonorgestrel [LNG] 90 μg/ethinylestradiol [EE] 20 μg)
Number of subjects: 147
Study 21417560 — intervention group
Group type: COMPARATOR
Intervention: Cyclic COC (LNG 100 μg/EE 20 μg, 21/7 days pattern)
Number of subjects: 147
Study 21417560 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous COC
Number of subjects: 147
Study 21417560 — intervention group
Group type: COMPARATOR
Intervention: Cyclic COC
Number of subjects: 147
Study 18344728 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg temazepam
Number of subjects: 0
Study 18344728 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg diphenhydramine
Number of subjects: 0
Study 18344728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16988930 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 0
Study 14680092 — intervention group
Group type: EXPERIMENTAL
Intervention: Dithiothreitol-formaldehyde mixture for 48-72 h before dispersal with trypsin (preservation method)
Number of subjects: 39
Study 14680092 — intervention group
Group type: COMPARATOR
Intervention: Routine method using dithiothreitol
Number of subjects: 39
Study 10764175 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure wristbands applied at P6 points
Number of subjects: 200
Study 10764175 — intervention group
Group type: COMPARATOR
Intervention: Control group with wristbands placed inappropriately on the posterior surface
Number of subjects: 200
Study 9214817 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracking tasks with visuoperceptual buffer-zone technique
Number of subjects: 32
Study 9214817 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmotor test of dynamic visuoperception
Number of subjects: 32
Study 9214817 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 32
Study 1486675 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular artemether plus oral mefloquine
Number of subjects: 141
Study 1486675 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous artesunate plus oral mefloquine
Number of subjects: 141
Study 1486675 — intervention group
Group type: COMPARATOR
Intervention: Intravenous quinine plus oral tetracycline
Number of subjects: 141
Study 7011353 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin 250 mg or 500 mg, orally three times daily for seven days
Number of subjects: 199
Study 7011353 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin 250 mg or 500 mg, orally three times daily for seven days
Number of subjects: 199